{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:33:52Z","timestamp":1791920032884,"version":"4.3.4"},"reference-count":79,"publisher":"Centers for Disease Control MMWR Office","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Recomm. Rep."],"DOI":"10.15585\/mmwr.rr7006a1","type":"journal-article","created":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T13:41:38Z","timestamp":1639662098000},"page":"1-16","source":"Crossref","is-referenced-by-count":90,"title":["Dengue Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021"],"prefix":"10.15585","volume":"70","author":[{"given":"Gabriela","family":"Paz-Bailey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua M.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A.","family":"Poehling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilbur H.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"McNally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Atmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen H.","family":"Waterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6224","published-online":{"date-parts":[[2021,12,17]]},"reference":[{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R1","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/S1473-3099(16)00026-8","article-title":"The global burden of dengue: an analysis from the Global Burden of Disease Study 2013.","volume":"16","author":"Stanaway","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R2","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/S1473-3099(16)00146-8","article-title":"The global economic burden of dengue: a systematic analysis.","volume":"16","author":"Shepard","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R3","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1038\/s41564-019-0476-8","article-title":"The current and future global distribution and population at risk of dengue.","volume":"4","author":"Messina","year":"2019","journal-title":"Nat Microbiol"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R4","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/S0140-6736(18)32560-1","article-title":"Dengue.","volume":"393","author":"Wilder-Smith","year":"2019","journal-title":"Lancet"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R5","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.4269\/ajtmh.14-0132","article-title":"Review article: research on dengue during World War II revisited.","volume":"91","author":"Snow","year":"2014","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R6","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4269\/ajtmh.1952.1.30","article-title":"Research on dengue during World War II.","volume":"1","author":"Sabin","year":"1952","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R7","doi-asserted-by":"publisher","first-page":"e2357","DOI":"10.1371\/journal.pntd.0002357","article-title":"Symptomatic versus inapparent outcome in repeat dengue virus infections is influenced by the time interval between infections and study year.","volume":"7","author":"Montoya","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R8","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1093\/infdis\/jit436","article-title":"A shorter time interval between first and second dengue infections is associated with protection from clinical illness in a school-based cohort in Thailand.","volume":"209","author":"Anderson","year":"2014","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R9","first-page":"311","article-title":"Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered.","volume":"42","author":"Halstead","year":"1970","journal-title":"Yale J Biol Med"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R10","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1093\/oxfordjournals.aje.a113932","article-title":"Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak.","volume":"120","author":"Sangkawibha","year":"1984","journal-title":"Am J Epidemiol"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R11","doi-asserted-by":"publisher","first-page":"40923","DOI":"10.1038\/srep40923","article-title":"Dengue virus compartmentalization during antibody-enhanced infection.","volume":"7","author":"Ong","year":"2017","journal-title":"Sci Rep"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R12","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00281-017-0625-1","article-title":"Immune-mediated cytokine storm and its role in severe dengue.","volume":"39","author":"Srikiatkhachorn","year":"2017","journal-title":"Semin Immunopathol"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R13","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-virology-101416-041848","article-title":"The good, the bad, and the shocking: the multiple roles of dengue virus nonstructural protein 1 in protection and pathogenesis.","volume":"5","author":"Glasner","year":"2018","journal-title":"Annu Rev Virol"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R14","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1126\/science.abb6143","article-title":"Zika virus infection enhances future risk of severe dengue disease.","volume":"369","author":"Katzelnick","year":"2020","journal-title":"Science"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.tmaid.2019.05.002","article-title":"Yellow fever (YF) vaccination does not increase dengue severity: a retrospective study based on 11,448 dengue notifications in a YF and dengue endemic region.","volume":"30","author":"Luppe","year":"2019","journal-title":"Travel Med Infect Dis"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R16","doi-asserted-by":"publisher","first-page":"e1311","DOI":"10.1371\/journal.pntd.0001311","article-title":"Preexisting Japanese encephalitis virus neutralizing antibodies and increased symptomatic dengue illness in a school-based cohort in Thailand.","volume":"5","author":"Anderson","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R17","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3389\/fimmu.2014.00280","article-title":"Epidemiological risk factors associated with high global frequency of inapparent dengue virus infections.","volume":"5","author":"Grange","year":"2014","journal-title":"Front Immunol"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R18","unstructured":"World Health Organization and the Special Programme for Research and Training in Tropical Diseases. Dengue: guidelines for diagnosis, treatment, prevention and control. Geneva, Switzerland: World Health Organization; 2009."},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R19","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jfma.2012.10.013","article-title":"Factors contributing to the disturbance of coagulation and fibrinolysis in dengue virus infection.","volume":"112","author":"Chuang","year":"2013","journal-title":"J Formos Med Assoc"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/14787210.2017.1248405","article-title":"Current management of severe dengue infection.","volume":"15","author":"Lee","year":"2017","journal-title":"Expert Rev Anti Infect Ther"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R21","doi-asserted-by":"publisher","first-page":"taz062","DOI":"10.1093\/jtm\/taz062","article-title":"Severe dengue in travellers: pathogenesis, risk and clinical management.","volume":"26","author":"Halstead","year":"2019","journal-title":"J Travel Med"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R22","first-page":"10","article-title":"Standardized clinical management: evidence of reduction of dengue haemorrhagic fever case-fatality rate in Thailand.","volume":"23","author":"Kalayanarooj","year":"1999","journal-title":"Dengue Bull"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R23","first-page":"105","article-title":"Dengue haemorrhagic fever in children in Delhi.","volume":"70","author":"Kabra","year":"1992","journal-title":"Bull World Health Organ"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R24","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJMoa044057","article-title":"Comparison of three fluid solutions for resuscitation in dengue shock syndrome.","volume":"353","author":"Wills","year":"2005","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R25","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1093\/cid\/cit594","article-title":"Clinical characteristics of dengue shock syndrome in Vietnamese children: a 10-year prospective study in a single hospital.","volume":"57","author":"Lam","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R26","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1128\/JCM.38.5.1823-1826.2000","article-title":"Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections.","volume":"38","author":"Martin","year":"2000","journal-title":"J Clin Microbiol"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R27","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12879-018-3058-0","article-title":"Prolonged persistence of IgM against dengue virus detected by commonly used commercial assays.","volume":"18","author":"Chien","year":"2018","journal-title":"BMC Infect Dis"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R28","first-page":"895","article-title":"Persistence of neutralizing antibody 30\u201335 years after immunization with 17D yellow fever vaccine.","volume":"59","author":"Poland","year":"1981","journal-title":"Bull World Health Organ"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R29","doi-asserted-by":"publisher","first-page":"154","DOI":"10.4269\/ajtmh.1983.32.154","article-title":"Original antigenic sin in dengue.","volume":"32","author":"Halstead","year":"1983","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R30","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6801a1","article-title":"Dengue and Zika virus diagnostic testing for patients with a clinically compatible illness and risk for infection with both viruses.","volume":"68","author":"Sharp","year":"2019","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R31","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1365-2915.2010.00864.x","article-title":"Septic tanks as larval habitats for the mosquitoes Aedes aegypti and Culex quinquefasciatus in Playa-Playita, Puerto Rico.","volume":"24","author":"Burke","year":"2010","journal-title":"Med Vet Entomol"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R32","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1365-2915.2008.00720.x","article-title":"Unusual productivity of Aedes aegypti in septic tanks and its implications for dengue control.","volume":"22","author":"Barrera","year":"2008","journal-title":"Med Vet Entomol"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1017\/S0007485300018630","article-title":"Mechanisms of insecticide resistance in Aedes aegypti (L.) (Diptera: Culicidae) from Puerto Rico.","volume":"79","author":"Hemingway","year":"1989","journal-title":"Bull Entomol Res"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R34","doi-asserted-by":"publisher","first-page":"e0007275","DOI":"10.1371\/journal.pntd.0007275","article-title":"Correction: alternative strategies for mosquito-borne arbovirus control.","volume":"13","author":"Achee","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R35","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.3201\/eid2510.181847","article-title":"Rapid screening of Aedes aegypti mosquitoes for susceptibility to insecticides as part of Zika emergency response, Puerto Rico.","volume":"25","author":"Hemme","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R36","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1093\/jme\/tjw115","article-title":"Knockdown resistance mutations in Aedes aegypti (Diptera: Culicidae) from Puerto Rico.","volume":"53","author":"Ponce-Garc\u00eda","year":"2016","journal-title":"J Med Entomol"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R37","doi-asserted-by":"publisher","first-page":"460","DOI":"10.2105\/AJPH.57.3.460","article-title":"Aedes aegypti eradication program of the United States\u2014progress report 1965.","volume":"57","author":"Schliessmann","year":"1967","journal-title":"Am J Public Health Nations Health"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R38","first-page":"107","article-title":"Dengue and dengue hemorrhagic fever in the Americas.","volume":"6","author":"Gubler","year":"1987","journal-title":"P R Health Sci J"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R39","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2105\/AJPH.53.1.7","article-title":"The elimination of urban yellow fever in the Americas through the eradication of Aedes aegypti.","volume":"53","author":"Soper","year":"1963","journal-title":"Am J Public Health Nations Health"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R40","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3201\/eid0401.980111","article-title":"Reemergence of dengue in Cuba: a 1997 epidemic in Santiago de Cuba.","volume":"4","author":"Kour\u00ed","year":"1998","journal-title":"Emerg Infect Dis"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R41","doi-asserted-by":"publisher","first-page":"taw062","DOI":"10.1093\/jtm\/taw062","article-title":"Evidence-based risk assessment and communication: a new global dengue-risk map for travellers and clinicians.","volume":"23","author":"Jentes","year":"2016","journal-title":"J Travel Med"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R42","unstructured":"Government of the Federated States of Micronesia. Dengue virus type-3 outbreak, Yap State: situational report #8 epi week #37: September 9\u201315, 2019\u2014report date: September 19, 2019. Micronesia (Federated States of) September 19, 2019."},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R43","unstructured":"CDC. CDC yellow book 2020: health information for international travel. New York, City NY: Oxford University Press; 2017"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R44","doi-asserted-by":"publisher","first-page":"149","DOI":"10.15585\/mmwr.mm6906a1","article-title":"Travel-associated and locally acquired dengue cases\u2014United States, 2010\u20132017.","volume":"69","author":"Rivera","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R45","doi-asserted-by":"publisher","first-page":"486","DOI":"10.4269\/ajtmh.14-0231","article-title":"Incidence of dengue virus infection in school-aged children in Puerto Rico: a prospective seroepidemiologic study.","volume":"92","author":"Arg\u00fcello","year":"2015","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R46","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1093\/trstmh\/try037","article-title":"Dengue seroprevalence: data from the clinical development of a tetravalent dengue vaccine in 14 countries (2005\u20132014).","volume":"112","author":"L\u2019Azou","year":"2018","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R47","doi-asserted-by":"publisher","first-page":"4848","DOI":"10.1016\/j.vaccine.2018.09.063","article-title":"Dengue vaccine: WHO position paper, September 2018\u2014recommendations.","volume":"37","year":"2019","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R48","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1056\/NEJMoa1800820","article-title":"Effect of dengue serostatus on dengue vaccine safety and efficacy.","volume":"379","author":"Sridhar","year":"2018","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R49","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/S0140-6736(20)30414-1","article-title":"Efficacy of a tetravalent dengue vaccine in healthy children aged 4\u201316 years: a randomised, placebo-controlled, phase 3 trial.","volume":"395","author":"Biswal","year":"2020","journal-title":"Lancet"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R50","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1586\/14760584.2016.1115727","article-title":"Development of TV003\/TV005, a single dose, highly immunogenic live attenuated dengue vaccine; what makes this vaccine different from the Sanofi-Pasteur CYD\u2122 vaccine?","volume":"15","author":"Whitehead","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R51","unstructured":"CDC. GRADE (Grading of Recommendations, Assessment, Development and Evaluation). Atlanta, GA: US Department of Health and Human Services, CDC; 2019."},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R52","unstructured":"Dengvaxia [Package Insert]. Swiftwater, PA: Sanofi; 2019."},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R53","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","article-title":"Efficacy and long-term safety of a dengue vaccine in regions of endemic disease.","volume":"373","author":"Hadinegoro","year":"2015","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R54","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1093\/cid\/ciab288","article-title":"Analysis of hospitalized and severe dengue cases over the 6 years of follow-up of the tetravalent dengue vaccine (CYD-TDV) efficacy trials in Asia and Latin America.","volume":"73","author":"Forrat","year":"2021","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R55","doi-asserted-by":"publisher","first-page":"6472","DOI":"10.1016\/j.vaccine.2020.07.056","article-title":"Efficacy after 1 and 2 doses of CYD-TDV in dengue endemic areas by dengue serostatus.","volume":"38","author":"Dayan","year":"2020","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R56","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S1473-3099(20)30767-2","article-title":"Immunogenicity and safety of simplified vaccination schedules for the CYD-TDV dengue vaccine in healthy individuals aged 9\u201350 years (CYD65): a randomised, controlled, phase 2, non-inferiority study.","volume":"21","author":"Coronel-Mart\u00cdnez","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R57","article-title":"Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"59","author":"Staples","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R58","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2217\/cer-2016-0045","article-title":"CYD-TDV dengue vaccine: systematic review and meta-analysis of efficacy, immunogenicity and safety.","volume":"6","author":"God\u00f3i","year":"2017","journal-title":"J Comp Eff Res"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R59","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.4161\/hv.25562","article-title":"Persistence of Th1\/Tc1 responses one year after tetravalent dengue vaccination in adults and adolescents in Singapore.","volume":"9","author":"Harenberg","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R60","doi-asserted-by":"publisher","first-page":"e1002181","DOI":"10.1371\/journal.pmed.1002181","article-title":"The long-term safety, public health impact, and cost-effectiveness of routine vaccination with a recombinant, live-attenuated dengue vaccine (Dengvaxia): a model comparison study.","volume":"13","author":"Flasche","year":"2016","journal-title":"PLoS Med"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R61","doi-asserted-by":"publisher","first-page":"e0009606","DOI":"10.1371\/journal.pntd.0009606","article-title":"Cost-effectiveness of dengue vaccination in Puerto Rico.","volume":"15","author":"Espa\u00f1a","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R62","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1093\/infdis\/jiw297","article-title":"Tetravalent dengue vaccine reduces symptomatic and asymptomatic dengue virus infections in healthy children and adolescents aged 2\u201316 years in Asia and Latin America.","volume":"214","author":"Olivera-Botello","year":"2016","journal-title":"J Infect Dis"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R63","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1542\/peds.2007-1115H","article-title":"Projected cost-effectiveness of new vaccines for adolescents in the United States.","volume":"121","author":"Ortega-Sanchez","year":"2008","journal-title":"Pediatrics"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R64","doi-asserted-by":"publisher","first-page":"e1006710","DOI":"10.1371\/journal.pcbi.1006710","article-title":"An agent-based model of dengue virus transmission shows how uncertainty about breakthrough infections influences vaccination impact projections.","volume":"15","author":"Perkins","year":"2019","journal-title":"PLOS Comput Biol"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R65","unstructured":"CDC. Dengue virus infections 2015 case definition. Atlanta, GA: US Department of Health and Human Services, CDC; 2015."},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R66","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1097\/INF.0000000000001250","article-title":"Immunogenicity and safety of yellow fever vaccine (Stamaril) when administered concomitantly with a tetravalent dengue vaccine candidate in healthy toddlers at 12\u201313 months of age in Colombia and Peru: a randomized trial.","volume":"35","author":"L\u00f3pez","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R67","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1097\/INF.0000000000001542","article-title":"Immunogenicity and safety of a booster injection of DTap-IPV\/\/Hib (Pentaxim) administered concomitantly with tetravalent dengue vaccine in healthy toddlers 15\u201318 months of age in Mexico: a randomized trial.","volume":"36","author":"Melo","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R68","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1097\/INF.0000000000000752","article-title":"First experience of concomitant vaccination against dengue and MMR in toddlers.","volume":"34","author":"Crevat","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R69","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1097\/INF.0000000000003164","article-title":"Immunogenicity and safety of a tetravalent dengue vaccine administered concomitantly or sequentially with quadrivalent human papillomavirus vaccine in boys and girls 9\u201313 years of age in Malaysia: a phase IIIb, randomized, open-label study.","volume":"40","author":"Hassan","year":"2021","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R70","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1016\/j.vaccine.2021.04.064","article-title":"Immunogenicity and safety of a tetravalent dengue vaccine and a bivalent HPV vaccine given concomitantly or sequentially in girls aged 9 to 14\u00a0years in Mexico.","volume":"39","author":"Arredondo","year":"2021","journal-title":"Vaccine"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R71","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1097\/INF.0000000000003220","article-title":"Immunogenicity and safety of a tetravalent dengue vaccine administered concomitantly or sequentially with Tdap vaccine: randomized phase IIIb trial in healthy participants 9\u201360 years of age in the Philippines.","volume":"40","author":"Santos","year":"2021","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R72","doi-asserted-by":"publisher","first-page":"e0009557","DOI":"10.1371\/journal.pntd.0009557","article-title":"Target product profile for a dengue pre-vaccination screening test.","volume":"15","author":"Fongwen","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R73","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/S1473-3099(18)30799-0","article-title":"Dengue pre-vaccination screening and positive predictive values.","volume":"19","author":"Rodr\u00edguez-Barraquer","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R74","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S1473-3099(19)30167-7","article-title":"Sensitivity and negative predictive value for a rapid dengue test.","volume":"19","author":"Flasche","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R75","unstructured":"CDC. Preventive service tables: prevention through health care. Atlanta, GA: US Department of Health and Human Services, CDC; 2020."},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R76","unstructured":"Esquilin I. Dengue vaccine knowledge and attitudes in Puerto Rico. Presented at the Advisory Committee on Immunization Practices Dengue Virus Vaccines meeting, Atlanta, GA; February 27, 2020."},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R77","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/S1473-3099(20)30722-2","article-title":"Optimising dengue pre-vaccination screening.","volume":"21","author":"Wilder-Smith","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R78","unstructured":"Hombach J. WHO global position on dengue vaccination. Presented at the Advisory Committee on Immunization Practices Dengue Virus Vaccines meeting, Atlanta, GA; February 27, 2020."},{"key":"key-10.15585\/mmwr.rr7006a1-202112161341-R79","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.coviro.2020.09.004","article-title":"Dengue vaccine development by the year 2020: challenges and prospects.","volume":"43","author":"Wilder-Smith","year":"2020","journal-title":"Curr Opin Virol"}],"container-title":["MMWR. Recommendations and Reports"],"original-title":[],"deposited":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T13:41:49Z","timestamp":1639662109000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/70\/rr\/RR7006a1.htm?s_cid=RR7006a1_w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,17]]},"references-count":79,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,12,17]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.rr7006a1","relation":{},"ISSN":["1057-5987","1545-8601"],"issn-type":[{"value":"1057-5987","type":"print"},{"value":"1545-8601","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,12,17]]},"published":{"date-parts":[[2021,12,17]]}}}